WallStreetZenWallStreetZen

NASDAQ: ATOS
Atossa Therapeutics Inc Stock Ownership - Who owns Atossa Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atossa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steven C. QuayPresident CEO2025-05-2111,239$0.88
$9.89kBuy
H. Lawrence RemmelDirector2025-03-2610,000$0.70
$7.00kBuy

1 of 1

ATOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATOS insiders and whales buy or sell their stock.

ATOS Shareholders

What type of owners hold Atossa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shuchih Chen7.04%9,095,173$7.64MInsider
Vanguard Group Inc4.52%5,833,127$4.90MInstitution
Steven C. Quay3.76%4,863,010$4.08MInsider
Ameriprise Financial Inc2.30%2,973,205$2.50MInstitution
Blackrock Inc1.66%2,148,010$1.80MInstitution
Millennium Management LLC1.59%2,047,535$1.72MInstitution
Renaissance Technologies LLC1.40%1,812,251$1.52MInstitution
Geode Capital Management LLC1.01%1,300,379$1.09MInstitution
State Street Corp0.40%516,571$433.92kInstitution
Jane Street Group LLC0.36%458,729$385.33kInstitution

1 of 3

ATOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATOS16.53%11.04%Net Buying
FBIO16.67%50.59%Net Buying
SPRO19.69%64.04%Net SellingNet Selling
ACHV72.33%27.67%Net SellingNet Selling
HLVX60.62%39.38%Net Selling
View Top Biotech Stocks

Atossa Therapeutics Stock Ownership FAQ

Who owns Atossa Therapeutics?

Atossa Therapeutics (NASDAQ: ATOS) is owned by 16.53% institutional shareholders, 11.04% Atossa Therapeutics insiders, and 72.43% retail investors. Shuchih Chen is the largest individual Atossa Therapeutics shareholder, owning 9.10M shares representing 7.04% of the company. Shuchih Chen's Atossa Therapeutics shares are currently valued at $7.44M.

If you're new to stock investing, here's how to buy Atossa Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.